Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted from a Chronic to an Episodic Migraine Classification

被引：0
|
作者：
Ailani, J.
Cohen, J. M.
Yugrakh, M. S.
Ning, X.
机构：
来源：
HEADACHE | 2019年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P147
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [1] Long-Term Impact of Fremanezumab on Headache-Related Disability and Quality of Life in Patients Who Reverted From a Chronic to an Episodic Migranie Classification
    Ailani, Jessica
    Cohen, Joshua
    Yugrakh, Marianna
    Yeung, Paul P.
    Ning, Xiaoping
    [J]. NEUROLOGY, 2019, 92 (15)
  • [2] Long-Term Impact of Fremanezumab on Headache-Related Disability, Quality of Life, and Patient Satisfaction in Episodic Migraine and Chronic Migraine
    Cohen, J. M.
    Saikali, N. P.
    Yang, R.
    Ning, X.
    [J]. HEADACHE, 2019, 59 : 114 - 115
  • [3] Long-Term Impact of Fremanezumab on Headache-Related Disability, Quality of Life, and Patient Satisfaction in Episodic Migraine and Chronic Migraine
    Cohen, Joshua
    Saikali, Nicolas
    Yeung, Paul P.
    Yang, Ronghua
    Ning, Xiaoping
    [J]. NEUROLOGY, 2019, 92 (15)
  • [4] Long-Term Efficacy of Fremanezumab in Patients Who Reverted From a Chronic to an Episodic Migraine Classification
    Lipton, Richard
    Cohen, Joshua
    Yeung, Paul P.
    Yang, Ronghua
    Seminerio, Michael
    Campos, Verena Ramirez
    Singh, Rashmi Halker
    Ailani, Jessica
    [J]. NEUROLOGY, 2019, 92 (15)
  • [5] Long-Term Efficacy of Fremanezumab in Patients Who Reverted from a Chronic to an Episodic Migraine Classification
    Lipton, R. B.
    Cohen, J. M.
    Yang, R.
    Seminerio, M. J.
    Campos, V. Ramirez
    Singh, R. B. Walker
    Ailani, J.
    [J]. HEADACHE, 2019, 59 : 101 - 102
  • [6] The Impact of Fremanezumab on Headache-Related Disability in Patients with Episodic Migraine using the Migraine Disability Assessment
    Winner, Paul K.
    Fitzgerald, Timothy
    Gandhi, Sanjay K.
    Yeung, Paul P.
    Cohen, Joshua M.
    Ma, Yuju
    Aycardi, Ernesto
    [J]. NEUROLOGY, 2018, 90
  • [7] The Impact of Fremanezumab on Headache-related Disability in Patients with Episodic Migraine Using the Migraine Disability Assessment
    Winner, P. K.
    Fitzgerald, T.
    Gandhi, S. K.
    Yeung, P. P.
    Cohen, J. M.
    Ma, Y.
    Aycardi, E.
    [J]. HEADACHE, 2018, 58 : 126 - 126
  • [8] The Impact of Fremanezumab on Headache-related Disability in Patients With Episodic Migraine Using the Migraine Disability Assessment
    Winner, Paul K.
    Fitzgerald, Timothy
    Gandhi, Sanjay K.
    Yeung, Paul P.
    Cohen, Joshua M.
    Ma, Yuju
    Aycardi, Ernesto
    [J]. JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [9] The impact of fremanezumab on headache-related disability in patients with chronic migraine using the Headache Impact Test
    Winner, Paul K.
    Fitzgerald, Timothy
    Gandhi, Sanjay K.
    Yeung, Paul P.
    Cohen, Joshua M.
    Ma, Yuju
    Aycardi, Ernesto
    [J]. JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [10] The Impact of Fremanezumab on Headache-Related Disability in Patients With Chronic Migraine Using the Headache Impact Test (HIT-6)
    Winner, Paul K.
    Fitzgerald, Timothy
    Gandhi, Sanjay K.
    Yeung, Paul P.
    Cohen, Joshua M.
    Yang, Ronghua
    Aycardi, Ernesto
    [J]. CEPHALALGIA, 2017, 37 : 332 - 332
12345